Cargando…

Mortality risk in patients infected with SARS-CoV-2 of the lineage B.1.1.7 in the UK

Detalles Bibliográficos
Autores principales:	Kow, Chia Siang, Merchant, Hamid A., Hasan, Syed Shahzad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117481/ https://www.ncbi.nlm.nih.gov/pubmed/33992685 http://dx.doi.org/10.1016/j.jinf.2021.05.008

Ejemplares similares

Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis
por: Kow, Chia Siang, et al.
Publicado: (2021)

The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
por: Hill, Verity, et al.
Publicado: (2022)

Correction to: The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK
Publicado: (2022)

The association between the use of ivermectin and mortality in patients with COVID-19: a meta-analysis
por: Kow, Chia Siang, et al.
Publicado: (2021)

The risk of mortality and severe illness in patients infected with the omicron variant relative to delta variant of SARS-CoV-2: a systematic review and meta-analysis
por: Kow, Chia Siang, et al.
Publicado: (2023)

Observations of SARS-CoV-2 variant of concern B.1.1.7 at the UK's largest hospital trust
por: Garvey, Mark I., et al.
Publicado: (2021)

Macrolides for patients with COVID-19 and concurrent pertussis infection
por: Kow, Chia Siang, et al.
Publicado: (2021)

Concurrent Antibiotic Therapy in Disseminated Strongyloidiasis
por: Kow, Chia Siang, et al.
Publicado: (2020)

Use of Azithromycin in COVID-19: A Cautionary Tale
por: Kow, Chia Siang, et al.
Publicado: (2020)

Revascularization strategy in patients with acute ST-elevation myocardial infarction amid COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2021)

Pharmacological Management of Obese Patients with Type 2 Diabetes amid COVID-19 Pandemic
por: Kow, Chia Siang, et al.
Publicado: (2020)

The use of antimotility drugs in COVID-19 associated diarrhea
por: Kow, Chia Siang, et al.
Publicado: (2021)

Neurohormonal treatment in tako-tsubo cardiomyopathy precipitated by COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Azithromycin in patients with COVID-19: Friend or foe?
por: Kow, Chia Siang, et al.
Publicado: (2021)

The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Pharmacologic therapeutic options for thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Use of DPP-4 inhibitors in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Special consideration in the dosing of medications for patients with COVID-19 and acute kidney injury
por: Kow, Chia Siang, et al.
Publicado: (2020)

Cerebral Venous Thrombosis following COVID-19 Vaccination
por: Kow, Chia Siang, et al.
Publicado: (2021)

Acute Heart Failure in Coronavirus Disease 2019 and the Management of Comedications
por: Kow, Chia Siang, et al.
Publicado: (2020)

A meta-analysis on the preadmission use of DPP-4 inhibitors and risk of a fatal or severe course of illness in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Potential interactions between COVID-19 vaccines and antiepileptic drugs
por: Kow, Chia Siang, et al.
Publicado: (2021)

Revascularization in COVID-19 patients with renal infarction
por: Kow, Chia Siang, et al.
Publicado: (2021)

Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7
por: Davies, Nicholas G., et al.
Publicado: (2021)

Report of SARS-CoV-2 B1.1.7 Lineage in Morocco
por: Ouadghiri, Mouna, et al.
Publicado: (2021)

Multiorgan tropism of SARS-CoV-2 lineage B.1.1.7
por: Ondruschka, Benjamin, et al.
Publicado: (2021)

Monitoring the rise of the SARS-CoV-2 lineage B.1.1.7 in Tenerife (Spain) since mid-December 2020
por: Alcoba-Florez, Julia, et al.
Publicado: (2021)

El uso de agentes antiplaquetarios para la tromboprofilaxis arterial en la COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Tratamiento neurohormonal en miocardiopatía de tako-tsubo precipitada por COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Mortality and Disease Severity Among COVID-19 Patients Receiving Renin-Angiotensin System Inhibitors: A Systematic Review and Meta-analysis
por: Hasan, Syed Shahzad, et al.
Publicado: (2020)

Epidemic Spread of SARS-CoV-2 Lineage B.1.1.7 in Brazil
por: Moreira, Filipe R. R., et al.
Publicado: (2021)

Quality of adverse event reporting in clinical trials of remdesivir in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

The risk of mortality in patients with COVID-19 with pre-diagnosis use of NSAIDs: a meta-analysis
por: Kow, Chia Siang, et al.
Publicado: (2021)

The effect of tocilizumab on mortality in hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials
por: Kow, Chia Siang, et al.
Publicado: (2021)

Initial viral load and decay kinetics of SARS-CoV-2 lineage B.1.1.7 in the upper respiratory tract of adults and children
por: Costa, Rosa, et al.
Publicado: (2021)

Lateral flow antigen tests can sensitively detect live cultured virus of the SARS-CoV-2 B1.1.7 lineage
por: Kontogianni, Konstantina, et al.
Publicado: (2021)

“Sehat Sahulat Program”: A Leap into the Universal Health Coverage in Pakistan
por: Hasan, Syed Shahzad, et al.
Publicado: (2022)

Anticoagulant approach in COVID-19 patients with cerebral venous thrombosis
por: Kow, Chia Siang, et al.
Publicado: (2020)

Use of aspirin for primary prevention in patients with diabetes during the COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2021)

Colchicine for COVID-19: Hype or hope?
por: Kow, Chia Siang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_94c421ooak2masvedqb5m753pa